Search

  • Search

    Request For Information – Supply of Boronophenylalanine for pharmaceutical preparation of compound for BNCT treatment

    HUS-yhtymä

    Request For Information – Supply of Boronophenylalanine for pharmaceutical preparation of compound for BNCT treatment

    1. Planning notice published

      Sep 2, 7:04 AMSeptember 2, 2026 7:04 AM

    Brief

    Finland: Tenders/HUS-yhtymä/Request For Information – Supply of Boronophenylalanine for pharmaceutical preparation of compound for BNCT treatment
    Brief

    Farmasøytisk engroshandel

    HUS Group, the joint authority for Helsinki and Uusimaa, is planning the procurement of L-4-boronophenylalanine (BPA) for the pharmaceutical preparation of a compound used in BNCT treatment. Suppliers are asked to provide information on order size, delivery time, shelf-life, quality assurance, and regulatory requirements, and can send questions to HUS Pharmacy to arrange an active discussion.

    About the bid

      HUS Pharmacy is searching for a new supplier of L-4-boronophenylalanine (synonyms: BPA, borofalan, 4-(borono- 10B)-L-phenylalanine), CAS No [80994-59-8]. The supplied BPA will be used in pharmaceutical preparation of BPA-fructose complex used in BNCT-treatment at HUS Comprehensive Cancer Centre. The aim of this RFI is to survey and identify suppliers with the capability to manufacture BPA on a scale and according to the medicinal grade specifications set by HUS Pharmacy. After this RFI HUS Pharmacy will conduct a formal tendering process to establish a multi-year supplier contract. The estimated consumption of BPA is 2-4 kilograms per year starting from 2028. This number can change, as the accelerator based BNCT treatment is a novel process and thus under constant clinical study and development. The specifications for BPA are set out in Attachment 1 to this notice. We ask the interested parties to provide as much as possible of the following information: •Approximate minimum and maximum size of order in grams or kilograms, when delivery is from a single production batch. •Approximate time from order to delivery to Finland. We acknowledge that the production of BPA requires several months to complete. •Shelf-life of product from batch release. If provider has an ongoing stability program to extend the shelf-life, then the expected future shelf-life information can also be noted. •Description of the quality assurance of the final product and quality management of the production process. •Any possible regulatory requirements regarding HUS Pharmacy when delivering boron-10 isotope to Finland, if the providers national regulations have such requirements. •Information about other possible boron-10 carriers available for BNCT treatment can be provided. The information can be provided in a format of your choice in English or Finnish. Responses provided by suppliers will be treated confidentially. Interested party can send questions regarding the RFI to HUS Pharmacy with the initial information, and an active discussion can be arranged upon request. RFI can be supplemented based on the dialogue. This is not a contract notice or a request for tenders, but a request for information (RFI). The purpose of the RFI is to assess the market, identify suppliers currently operating in the market, and obtain information on their product portfolios. The RFI does not invite or request the submission of tenders, and this notice does not initiate a competitive tendering process. The information presented in this notice, as well as any information provided during the market consultation, is preliminary and indicative. HUS is under no obligation to proceed with the procurement or to adopt any procurement method. HUS will not pay any compensation for responding to the RFI or participating in the market consultation. Responding to the RFI does not oblige the supplier to participate in any subsequent competitive tendering process, nor is it a prerequisite for participating in any subsequent procurement procedure. Whether or not a supplier responds to the RFI will have no bearing on the supplier’s position in any subsequent competitive tendering process.

      Contact name
      HUS Pharmacy
      Contact phone
      +35894711
      Contact email
      laakehankinnat@hus.fi
      Address
      PL 441 (Uutistie 5, 01770 Vantaa), 00029 HUS

    Custom Assessment Criteria

    Start a free trial to ask your own questions about the tender and get AI-generated answers.

    Award Criteria

      Found no award criteria in the contract notice.

    Qualification requirements

      Found no qualification requirements in the contract notice.

    Previous Contract Winners

    Start a free trial to see who has won similar tenders for this buyer.

    See the full notice

    Contracting authority
    HUS-yhtymä
    Title
    Request For Information – Supply of Boronophenylalanine for pharmaceutical preparation of compound for BNCT treatment
    Type
    Planning
    Main code
    33600000Pharmaceutical products
    Supplemental codes

    No supplemental codes from buyer…

    Location
    Helsinki-Uusimaa

    Active similar competitions

    • HUS-yhtymä

      Medisinsk og laboratorieutstyr

      Request for information: Radioactive seeds (I-125) and plaques (Ru-106) used in eye brachytherapy

      HUS Group is planning the procurement of radioactive products, specifically Iodine-125 (I-125) brachytherapy seeds and Ruthenium-106 (Ru-106) eye plaques/applicators, along with related accessories for the treatment of epibulbar and intraocular tumors. Suppliers are asked to provide information on their product portfolios, typical delivery times, and available options for accessories, quality assurance, and treatment planning systems by submitting their responses via email to kilpailutus.tiimi@hus.fi. Eckert & Ziegler BEBIG GmbH likely has the contract today.

      PlanningOct 5, 2026
      Jan 25, 2027(106 days)

    • HUS-yhtymä

      Medisinsk og laboratorieutstyr

      REQUEST FOR INFORMATION: SPRI Beads

      HUS-yhtymä is planning the procurement of DNA size selection reagents based on paramagnetic beads, utilizing SPRI technology for selective binding and purification of DNA fragments, to be used in next-generation sequencing (NGS) library preparation. Suppliers can provide feedback and input by submitting a response via email to kilpailutus.diagnostiikka@hus.fi, addressing all requirements, providing requested information and documentation, and identifying any concerns or proposed amendments to the draft agreement.

      PlanningAug 18, 2026
      Nov 1, 2026(21 days)

    • Päijät-Hämeen hyvinvointialue

      Medisinsk og laboratorieutstyr

      Tietopyyntö: Gammadetektori

      Päijät-Hämeen hyvinvointialue suunnittelee gammadetektorin hankintaa rintasyöpäleikkauksia varten, ja laitteen avulla paikannetaan imusolmukkeet, joihin radioaktiivinen merkkiaine on kulkeutunut. Hankinnan kohteena on langaton gammadetektori, jossa on langaton käsiosa paremman steriliteetin takaamiseksi leikkauksessa. Ostaja pyytää tietoa alalla toimivilta toimittajilta ja markkinoilla saatavilla olevista ratkaisuista markkinakartoituksen yhteydessä.

      PlanningJul 9, 2026

    • HUS-yhtymä

      REQUEST FOR INFORMATION: HUS 364-2026 Osseointegrated implant systems

      HUS Group is planning the procurement of osseointegrated implant systems for patients with upper and/or lower limb loss, including intramedullary osseointegrated implants, fixation components, prosthetic attachment systems, surgical instruments, and related digital solutions and services. Suppliers are invited to provide information on their products, clinical evidence, regulatory compliance, and support services by submitting responses electronically to kilpailutus.kirurgia@hus.fi. HUS procurement may also invite selected suppliers to participate in a market dialogue meeting via Microsoft Teams to gather further information.

      PlanningAug 13, 2026
      Dec 13, 2026(63 days)